As of 2025-04-22, the EV/EBITDA ratio of Inhibrx Inc (INBX) is -0.04. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INBX's latest enterprise value is 12.19 mil USD. INBX's TTM EBITDA according to its financial statements is -329.09 mil USD. Dividing these 2 quantities gives us the above INBX EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 9.0x - 10.8x | 9.8x |
| Forward P/E multiples | 15.2x - 30.0x | 19.5x |
| Fair Price | (194.01) - 3,666.59 | 1,088.18 |
| Upside | -1804.8% - 32119.6% | 9462.3% |
| Date | EV/EBITDA |
| 2025-04-21 | -0.04 |
| 2025-04-17 | -0.04 |
| 2025-04-16 | -0.04 |
| 2025-04-15 | -0.06 |
| 2025-04-14 | -0.06 |
| 2025-04-11 | -0.05 |
| 2025-04-10 | -0.03 |
| 2025-04-09 | -0.08 |
| 2025-04-08 | -0.05 |
| 2025-04-07 | -0.06 |
| 2025-04-04 | -0.12 |
| 2025-04-03 | -0.12 |
| 2025-04-02 | -0.16 |
| 2025-04-01 | -0.15 |
| 2025-03-31 | -0.15 |
| 2025-03-28 | -0.16 |
| 2025-03-27 | -0.17 |
| 2025-03-26 | -0.16 |
| 2025-03-25 | -0.16 |
| 2025-03-24 | -0.18 |
| 2025-03-21 | -0.17 |
| 2025-03-20 | -0.16 |
| 2025-03-19 | -0.15 |
| 2025-03-18 | -0.15 |
| 2025-03-17 | -0.15 |
| 2025-03-14 | -0.16 |
| 2025-03-13 | -0.16 |
| 2025-03-12 | -0.18 |
| 2025-03-11 | -0.13 |
| 2025-03-10 | -0.11 |
| 2025-03-07 | -0.13 |
| 2025-03-06 | -0.12 |
| 2025-03-05 | -0.14 |
| 2025-03-04 | -0.13 |
| 2025-03-03 | -0.13 |
| 2025-02-28 | -0.12 |
| 2025-02-27 | -0.09 |
| 2025-02-26 | -0.09 |
| 2025-02-25 | -0.08 |
| 2025-02-24 | -0.09 |
| 2025-02-21 | -0.09 |
| 2025-02-20 | -0.10 |
| 2025-02-19 | -0.10 |
| 2025-02-18 | -0.11 |
| 2025-02-14 | -0.13 |
| 2025-02-13 | -0.11 |
| 2025-02-12 | -0.10 |
| 2025-02-11 | -0.09 |
| 2025-02-10 | -0.09 |
| 2025-02-07 | -0.09 |